• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    More On CIR.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Opthea Limited (CIR.AX)

    -ASX
    0.31 0.00(0.00%) Dec 10
    Prev Close:0.31
    Open:0.30
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.30 - 0.31
    52wk Range:0.14 - 0.37
    Volume:70,000
    Avg Vol (3m):N/A
    Market Cap:46.56M
    P/E (ttm):N/A
    EPS (ttm):-0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Headlines

    • No Headlines available for CIR.AX at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):80.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. Its development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and R3 targets, w... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback